Nemoto Science Co.,Ltd

Corporate profile

FoundedMay 2000
Capital
80,000,000(Yen)
ChairmanIkuyoshi Nemoto
PresidentHiroki Tomisawa Ph.D.
DirectorsAkio Morohashi Ph.D.
Mieko Nemoto
Hiroki Yonekawa
AuditorShinichi Watanabe

Head Office

4-10-9 Takaido-Higashi,Suginami-ku,Tokyo 168-0072,Japan

Parent Company

Tsukuba Laboratories

6136-4 Ohnogo-machi,Joso-shi,Ibaraki-ken 300-2521,Japan
TEL:+81-297-24-0781
FAX:+81-297-24-1047

NEMOTO & CO., LTD.

4-10-9 Takaido-Higashi,Suginami-ku,Tokyo 168-0072,Japan

https://www.nemoto.co.jp/en/

TOPへ戻る

Contract research for drug discovery and development

Drug discovery research

Radio-synthesis and purification
In vivo/In vitro phamacokinetic studies

Pre-clinical development (Data Integrity Standards*)

Radio-synthesis and purification
In vivo/in vitro pharmacokinetic studies
Toxicokinetic studies(GLP)

Clinical development (Data Integrity Standards* or GLP**)

Phase Ⅰ-Ⅳ studies
Bioequivalence studies

Stability test (Data Integrity Standards*)

Identification and Assay
performance tests
*Data Integrity Standards:"Data Integrity Standards for Product Application":Japanese regulations
**GLP:Good Laboratory Practice

Competitive Advantage
Well-trained technicians
Competent instruments
Report written in CTD
Use of a variiety of radioisotopes permitted

³H,¹⁴C,²²Na,³²P,³⁵S,⁴⁵Ca,⁵¹Cr,⁵⁷Co,⁵⁹Fe,⁶⁵Zn,⁹⁹Mo-⁹⁹mTc,¹¹⁰mAg,¹¹¹In,¹²³I,¹²⁵I,¹³¹I,¹⁴⁷Pm,¹⁵³Gd
Contract research for drug discovery and development
Contract research for drug discovery and development
Contract research for drug discovery and development
Contract research for drug discovery and development
TOPへ戻る

History

Dec. 1941  Founded for the production and sales of self-luminous paints for watches, clocks, instrument dials, etc.

Feb.  1984  Started custom syntheses of radiolabeled compounds for ADME studies at Tokyo laboratories of Nemoto & Co., Ltd.

Oct.  1986  Started contract ADME studies on radiolabeled compounds at Tsukuba laboratories of Nemoto & Co., Ltd.

Jun.  1995  Started contract research business for toxicokinitic analysis in accordance with GLP

Aug. 1998  Obtained the rating “A” upon GLP compliance inspection

May. 2000  Established Nemoto & Co., Ltd. taking over all operations from the Life Science division of Nemoto & Co., Ltd.

Jun.  2002  Obtained the rating “A” upon GLP compliance inspection.

Aug. 2005  Obtained the rating “A” upon GLP compliance inspection

Jan.  2006  Cooperated with Institute of Accelerator Analysis Ltd. and started contract clinical research using AMS detection

Jun.  2008  Obtained the rating “A” upon GLP compliance inspection

Jun.  2011  Obtained the rating “A” upon GLP compliance inspection

Feb.  2014   Started contract research business for stability test for formulations

Jul.   2014   Obtained the rating “A” upon GLP compliance inspection

Mar. 2015   Obtained certification for animal experimentation facilities from Japan Health Science Foundation

Aug. 2017   Obtained “compliant” upon GLP compliance inspection

Mar. 2018   Obtained certification for animal experimentation facilities from Japan Health Science Foundation (continuing)

Dec. 2020   Obtained “compliant” upon GLP compliance inspection

Sep. 2021   Started business collaboration with LSIM Safety Institute Corporation on NonClinical Pharmacokinetics research services

Contact Us

Tsukuba Laboratories
6136-4 Ohnogo-machi,Joso-shi,Ibaraki-ken 300-2521,Japan

E-mail busi-dep@nemotoscience.co.jp
https://www.nemotoscience.co.jp

TEL:+81-297-24-0781
FAX:+81-297-24-1047

TOPへ戻る